Literature DB >> 32827689

Muscle fiber-type specific terminal Schwann cell pathology leads to sprouting deficits following partial denervation in SOD1G93A mice.

Julia M Harrison1, Victor F Rafuse2.   

Abstract

Amyotrophic lateral sclerosis (ALS) is an adult-onset disease characterized by the progressive death of motoneurons and denervation of muscle fibers. To restore motor function, surviving motoneurons in partially denervated muscles typically sprout axons to reinnervate denervated endplates. However, studies on the SOD1G93A rodent models of ALS indicate that sprouting is significantly limited in fast, but not slow, twitch muscles after disease onset. This limitation hastens the rate of muscle weakness and loss of motor function. The causes of this limitation are currently unknown. Sprouting could be limited because the SOD1G93A mutation weakens motoneurons making them incapable of expanding their field of innervation. Alternatively, motoneurons may be capable of sprouting, but unable to do so due to the loss of a permissive sprouting environment. To distinguish between the two possibilities, we compared the sprouting capacity of motoneuron subtypes by partially denervating the fast twitch plantaris (composed of type IIa/IIb muscle fibers) and slow twitch soleus muscles (type I/IIa fibers) prior to disease onset and weakening in SOD1G93A and WT mice. We found that only motoneurons innervating the SOD1G93A plantaris had a limited sprouting capacity. This was correlated with the selective loss of terminal Schwann cells (TSCs) at IIb fibers and an increase in macrophage infiltration. Treating SOD1G93A mice with the tyrosine kinase inhibitor, masitinib, significantly reduced infiltration, prevented TSC loss, and increased the sprouting capacity to near normal. These results suggest that TSCs at denervated type IIb muscle fibers are aberrantly targeted by infiltrating macrophages in SOD1G93A mice, and their loss accounts, at least in part, for the compromised sprouting capacity of the largest motoneurons during early stages of ALS. Crown
Copyright © 2020. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALS; Endplate; Motoneuron; Muscle; Neuromuscular junction; Plasticity

Year:  2020        PMID: 32827689     DOI: 10.1016/j.nbd.2020.105052

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  8 in total

1.  Boosting the peripheral immune response in the skeletal muscles improved motor function in ALS transgenic mice.

Authors:  Maria Chiara Trolese; Carlotta Scarpa; Valentina Melfi; Paola Fabbrizio; Francesca Sironi; Martina Rossi; Caterina Bendotti; Giovanni Nardo
Journal:  Mol Ther       Date:  2022-04-27       Impact factor: 12.910

2.  Long-term survival analysis of masitinib in amyotrophic lateral sclerosis.

Authors:  Jesus S Mora; Walter G Bradley; Delia Chaverri; María Hernández-Barral; Javier Mascias; Josep Gamez; Gisella M Gargiulo-Monachelli; Alain Moussy; Colin D Mansfield; Olivier Hermine; Albert C Ludolph
Journal:  Ther Adv Neurol Disord       Date:  2021-07-19       Impact factor: 6.570

Review 3.  The Role of Sonic Hedgehog Pathway in the Development of the Central Nervous System and Aging-Related Neurodegenerative Diseases.

Authors:  Chen Yang; Yan Qi; Zhitang Sun
Journal:  Front Mol Biosci       Date:  2021-07-08

4.  Astrocyte-targeting RNA interference against mutated superoxide dismutase 1 induces motoneuron plasticity and protects fast-fatigable motor units in a mouse model of amyotrophic lateral sclerosis.

Authors:  Cylia Rochat; Nathalie Bernard-Marissal; Emma Källstig; Sylvain Pradervand; Florence E Perrin; Patrick Aebischer; Cédric Raoul; Bernard L Schneider
Journal:  Glia       Date:  2022-01-03       Impact factor: 8.073

5.  Functional adaptation of glial cells at neuromuscular junctions in response to injury.

Authors:  Anna P Perez-Gonzalez; Frédéric Provost; Isabelle Rousse; Roberta Piovesana; Ouafa Benzina; Houssam Darabid; Benoit Lamoureux; Yu Shi Wang; Danielle Arbour; Richard Robitaille
Journal:  Glia       Date:  2022-04-27       Impact factor: 8.073

Review 6.  Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact.

Authors:  Fabiola De Marchi; Ivana Munitic; Amedeo Amedei; James D Berry; Eva L Feldman; Eleonora Aronica; Giovanni Nardo; Donatienne Van Weehaeghe; Elena Niccolai; Nikolina Prtenjaca; Stacey A Sakowski; Caterina Bendotti; Letizia Mazzini
Journal:  Neurosci Biobehav Rev       Date:  2021-06-19       Impact factor: 9.052

7.  The pathogenic role of c-Kit+ mast cells in the spinal motor neuron-vascular niche in ALS.

Authors:  Mariángeles Kovacs; Catalina Alamón; Cecilia Maciel; Valentina Varela; Sofía Ibarburu; Lucas Tarragó; Peter H King; Ying Si; Yuri Kwon; Olivier Hermine; Luis Barbeito; Emiliano Trias
Journal:  Acta Neuropathol Commun       Date:  2021-08-13       Impact factor: 7.801

Review 8.  Small junction, big problems: Neuromuscular junction pathology in mouse models of amyotrophic lateral sclerosis (ALS).

Authors:  Abrar Alhindi; Ines Boehm; Helena Chaytow
Journal:  J Anat       Date:  2021-06-07       Impact factor: 2.921

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.